Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46001058BKPyvENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS46001458BKPyvENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS10018710HBVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30010291HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30017984HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034815HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034816HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034817HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034818HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034819HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TCGA Plot Options
Drug Information
GeneFLT1
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0000029
UniProt IDP17948
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830